Evidence map›Paper›PMID 26063234›Full record

ArticleDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2015

Curcumin as a double-edged sword for stem cells: dose, time and cell type-specific responses to curcumin.

Fatemeh Attari, Maryam Zahmatkesh, Hadi Aligholi, Shahram Ejtemaei Mehr, Mohammad Sharifzadeh, Ali Gorji, Tahmineh Mokhtari, Mojtaba Khaksarian, Gholamreza Hassanzadeh

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Effects of SRWFood & nutrition research · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Investigation of the effects of umbilical cord-derived mesenchymal stem cells and curcumin on Achilles tendon healing - can they act synergistically?Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2023
    Article
  13. Article
  14. Curcumin ameliorates chronicIranian journal of basic medical sciences · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Fatemeh AttariDepartment of Neuroscience, School of Advanced Technologies in medicine, Tehran University of Medical Sciences, Tehran, Iran. feriattari@gmail.com.
Maryam ZahmatkeshDepartment of Neuroscience, School of Advanced Technologies in medicine, Tehran University of Medical Sciences, Tehran, Iran. zahmatkm@tums.ac.ir.
Hadi AligholiDepartment of Neuroscience, School of Advanced Technologies in medicine, Tehran University of Medical Sciences, Tehran, Iran. hadialigholi@yahoo.com.
Shahram Ejtemaei MehrDepartment of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. ejtem@yahoo.com.
Mohammad SharifzadehFaculty of Pharmacy, and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran. msharifzadeh@tums.ac.ir.
Ali GorjiShefa Neuroscience Research Center, Khatamolanbia Hospital, Tehran, Iran. f_attari2004@yahoo.com.
Tahmineh MokhtariDepartment of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. mokhtari.tmn@gmail.com.
Mojtaba KhaksarianDepartment of Physiology, Medical College, Lorestan University of Medical Sciences, Khorramabad, Iran. mojkhaksar@yahoo.com.
Gholamreza HassanzadehDepartment of Neuroscience, School of Advanced Technologies in medicine, Tehran University of Medical Sciences, Tehran, Iran. hassanzadeh@tums.ac.ir.
Tehran University of Medical Sciences · IRLorestan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe beneficial effects of curcumin which includes its antioxidant, anti-inflammatory and cancer chemo-preventive properties have been identified. Little information is available regarding the optimal dose and treatment periods of curcumin on the proliferation rate of different sources of stem cells.

methodsIn this study, the effect of various concentrations of curcumin on the survival and proliferation of two types of outstanding stem cells which includes bone marrow stem cells (BMSCs) and adult rat neural stem/progenitor cells (NS/PCs) at different time points was investigated. BMSCs were isolated from bilateral femora and tibias of adult Wistar rats. NS/PCs were obtained from subventricular zone of adult Wistar rat brain. The curcumin (0.1, 0.5, 1, 5 and 10 μM/L) was added into a culture medium for 48 or 72 h. Fluorescent density of 5-bromo-2'-deoxyuridine (Brdu)-positive cells was considered as proliferation index. In addition, cell viability was assessed by MTT assay.

resultsTreatment of BMSCs with curcumin after 48 h, increased cell survival and proliferation in a dose-dependent manner. However, it had no effect on NSCs proliferation except a toxic effect in the concentration of 10 μM of curcumin. After a 72 h treatment period, BMSCs and NS/PCs survived and proliferated with low doses of curcumin. However, high doses of curcumin administered for 72 h showed toxic effects on both stem cells.

conclusionsThese findings suggest that curcumin survival and proliferative effects depend on its concentration, treatment period and the type of stem cells. Appropriate application of these results may be helpful in the outcome of combination therapy of stem cells and curcumin.

Indexed as

AnimalsBone Marrow CellsCell ProliferationCells, CulturedCell SurvivalCurcuminDose-Response Relationship, DrugFemurMaleMesenchymal Stem CellsNeural Stem CellsRats, WistarTibiaCurcumin

Identifiers

PMID26063234
PMCPMC4466857
OpenAlexW2131605932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.